There are currently, however, two radioligands that are United States Food and Drug Administration (FDA)-approved for the treatment of mCRPC patients: Patients with advanced prostate cancer are at ...

Lung metastasis (from metastatic breast cancer) resolved - after only 2 months (4 doses) of treatment with Bria-OTS™ ...

Therapeutics announces an unprecedented clinical response including resolution of a lung metastasis with stable disease ...

Lung metastasis (from metastatic breast cancer) resolved - after only 2 months (4 doses) of treatment with Bria-OTS ...

During a Case-Based Roundtable event, Laura Huppert, MD, discussed data and considerations around using T-DXd in breast ...

The management of bone metastases in endocrine-related cancers is a continually evolving field, marked by significant challenges and advances that affect ...

On World Cancer Day, we got in touch with an Orthopaedic Oncologist who shares the importance of early detection and expert ...

Medically reviewed by Aleesha Grier, PsyD Metastatic breast cancer affects people in many ways. The symptoms experienced by ...

The European Medicines Agency has recommended three new medicines to treat breast and cervical cancer and ...

Since the initial diagnosis, Prof Crellin has undergone chemotherapy and radiotherapy and continues to receive hormone ...

The 80-patient placebo-controlled randomized Phase 2 study will evaluate the efficacy of opaganib in combination with Bayer's darolutamide in men with metastatic castrate-resistant prostate cancer ...